Johnson & Johnson
JNJ · NYSE
9/28/2025 | 6/29/2025 | 3/30/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $441,082 | $369,518 | $398,949 | $348,089 |
| - Cash | $18,231 | $18,577 | $38,474 | $24,105 |
| + Debt | $6,387 | $50,761 | $52,252 | $36,634 |
| Enterprise Value | $429,238 | $401,702 | $412,727 | $360,618 |
| Revenue | $23,993 | $23,743 | $21,893 | $22,520 |
| % Growth | 1.1% | 8.5% | -2.8% | – |
| Gross Profit | $16,690 | $16,115 | $14,536 | $15,392 |
| % Margin | 69.6% | 67.9% | 66.4% | 68.3% |
| EBITDA | $9,288 | $8,742 | $15,607 | $5,920 |
| % Margin | 38.7% | 36.8% | 71.3% | 26.3% |
| Net Income | $5,152 | $5,537 | $10,999 | $3,431 |
| % Margin | 21.5% | 23.3% | 50.2% | 15.2% |
| EPS Diluted | 2.12 | 2.29 | 4.54 | 1.41 |
| % Growth | -7.4% | -49.6% | 222% | – |
| Operating Cash Flow | $9,169 | $3,878 | $4,174 | $6,983 |
| Capital Expenditures | -$788 | -$1,398 | -$809 | -$2,145 |
| Free Cash Flow | $8,381 | $2,480 | $3,365 | $4,838 |